Growth Metrics

Innoviva (INVA) Capital Expenditures (2016 - 2024)

Historic Capital Expenditures for Innoviva (INVA) over the last 13 years, with Q3 2024 value amounting to $270000.0.

  • Innoviva's Capital Expenditures rose 384.62% to $270000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $530000.0, marking a year-over-year increase of 6257.67%. This contributed to the annual value of $270000.0 for FY2024, which is 3430.66% down from last year.
  • Latest data reveals that Innoviva reported Capital Expenditures of $270000.0 as of Q3 2024, which was up 384.62% from $260000.0 recorded in Q3 2023.
  • Innoviva's 5-year Capital Expenditures high stood at $270000.0 for Q3 2024, and its period low was $9000.0 during Q1 2022.
  • Moreover, its 4-year median value for Capital Expenditures was $33000.0 (2022), whereas its average is $90142.9.
  • Its Capital Expenditures has fluctuated over the past 5 years, first soared by 68787.88% in 2023, then skyrocketed by 384.62% in 2024.
  • Innoviva's Capital Expenditures (Quarter) stood at $13000.0 in 2020, then skyrocketed by 153.85% to $33000.0 in 2022, then skyrocketed by 687.88% to $260000.0 in 2023, then increased by 3.85% to $270000.0 in 2024.
  • Its Capital Expenditures was $270000.0 in Q3 2024, compared to $260000.0 in Q3 2023 and $33000.0 in Q1 2023.